Clinical Medicine Insights: Therapeutics

Pregabalin and Fibromyalgia Syndrome: A Treatment Option

Submit a Paper

Clinical Medicine Insights: Therapeutics 2009:1 809-824


Published on 15 Jul 2009

Further metadata provided in PDF

Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Insights: Therapeutics


Fibromyalgia (FM) is a chronic complex pain disorder that is multidimensional and exhibits heterogeneity requiring a long-term multidisciplinary approach to management. Many of the drugs used in the treatment of FM have been focused to the management of single symptoms; often such drugs fail to demonstrate acceptable efficacy in the majority of the patient population. Pregabalin is an α2-δ ligand that regulates the release and postsynaptic actions of neurotransmitters related to analgesic, anticonvulsant and anxiolytic properties. In randomized, double-blind, placebo-controlled studies, pregabalin has demonstrated an improvement in pain, sleep and fatigue symptoms associated with FM, as well as offering an improvement in parameters related to quality of life. Although the positive outcomes obtained with pregabalin support its use as an option for the management of FM, the efficacy was restricted to a selected patient population outside of the usual care setting. Current data do not allow an explanation where there are any limitations of pregabalin as a treatment of patients with FM, as to whether this is a deficiency of the drug or the process of assessment (e.g. assessment tools of FM, clinical trial design).




BibTex citation   (BIBDESK, LATEX)

What Your Colleagues Say About Clinical Medicine Insights: Therapeutics
My submission to Libertas was one of the easiest and most time-efficient publication processes I have come across.  From the quick response of the reviewers to the rapid return of the proofs, I was amazed at how quickly my article was "publication ready"!  Thanks for such a painless publication process.
Dr Gerald W Dryden MD (University of Louisville, Louisville, Kentucky, USA)
More Testimonials

Quick Links

New article and journal news notification services